120 related articles for article (PubMed ID: 25242236)
21. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
[TBL] [Abstract][Full Text] [Related]
22. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.
Pilati C; Zucman-Rossi J
Cytokine Growth Factor Rev; 2015 Oct; 26(5):499-506. PubMed ID: 26188635
[TBL] [Abstract][Full Text] [Related]
23. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
24. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
25. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
26. The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
Han X; Xue L; Zhou L; Gong L; Zhu S; Yao L; Wang S; Lan M; Li Y; Zhang W
Exp Mol Pathol; 2013 Dec; 95(3):270-5. PubMed ID: 23906871
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
28. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
[TBL] [Abstract][Full Text] [Related]
29. Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.
Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
[TBL] [Abstract][Full Text] [Related]
30. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S; Amessou M; Couchy G; Poussin K; Imbeaud S; Pilati C; Izard T; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Nature; 2009 Jan; 457(7226):200-4. PubMed ID: 19020503
[TBL] [Abstract][Full Text] [Related]
31. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
[TBL] [Abstract][Full Text] [Related]
33. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
Zhao MM; Zhang Y; Shen L; Ren YW; Li XL; Yin ZH; Zhou BS
Asian Pac J Cancer Prev; 2014; 15(6):2809-13. PubMed ID: 24761905
[TBL] [Abstract][Full Text] [Related]
34. Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.
Jiang R; Jin Z; Liu Z; Sun L; Wang L; Li K
Mol Diagn Ther; 2011 Dec; 15(6):347-52. PubMed ID: 22208386
[TBL] [Abstract][Full Text] [Related]
35. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R
Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393
[TBL] [Abstract][Full Text] [Related]
36. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
37. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer.
Yano M; Ouchida M; Shigematsu H; Tanaka N; Ichimura K; Kobayashi K; Inaki Y; Toyooka S; Tsukuda K; Shimizu N; Shimizu K
Int J Cancer; 2004 Oct; 112(1):8-13. PubMed ID: 15305370
[TBL] [Abstract][Full Text] [Related]
39. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
